Prevalence of Antihepatitis C Antibodies in Patients Treated with Continuous Ambulatory Peritoneal Dialysis and Hemodialysis

Viral hepatitis infections among dialysis patients: Thailand registry report

“…The incidence of HCV infection in our study was 0.7%, which was similar to the recent reports from other countries of 0.34–1.7% per year 37,38 . In addition, the prevalence and incidence of HCV infection were not different among patients receiving HD and CAPD in our study while other reports showed lower prevalence of HCV infection in CAPD patients 39,40 . HCV infection is a significant problem in dialysis patients because progression of the infection may contribute to increase mortality from liver‐related death 8 …”

“…37,38 In addition, the prevalence and incidence of HCV infection were not different among patients receiving HD and CAPD in our study while other reports showed lower prevalence of HCV infection in CAPD patients. 39,40 HCV infection is a significant problem in dialysis patients because progression of the infection may contribute to increase mortality from liver-related death. 8 Our study showed that the mean duration of acquiring HCV was 59.1 months, which was longer than other studies.…”

Hepatitis C Virus Infection in Dialysis and Clinical Nephrology

“…In these reports, the number of blood transfusions before transplantation was identified as an important risk factor. The prevalence of anti-HCV positivity in patients on CAPD (continuous ambulatory peritoneal dialysis) is significantly lower compared to HD patients, indicating that CAPD patients are at lower risk of acquiring HCV infection (81)(82)(83)(84)(85)(86)(87). Several factors could contribute to this difference: CAPD is primarily a home procedure, and this may limit the risk of acquiring HCV infection by nosocomial spread.…”